Form 4 for MGNX MACROGENICS INC
Accepted 2024-02-07 00:00:00 ET · period of report 2024-02-07 · accession 0001125345-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | 2024-02-07 | MGNX | Bonvini Ezio | SVP, CSO, Research | S - Sale | $18.00 | -3,334 | 71.3K | -4% | -$60.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-07 | S | D | 3,334 | $18.00 | 71,334 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. |